2020 AGENDA
Day 01
Wednesday, May 13, 2020
Chairman’s Opening Address
Eldora Ellison, Director, Sterne Kessler Goldstein & Fox
Global Patent Protection: Retrospective and Outlook
David Gindler, Partner, Milbank
Disseminating Scientific Innovation: How is the Global CRISPR Patent Fight Playing Out?
Benjamin Sodey, Senior Corporate Patent Counsel, Millipore Sigma
PANEL DISCUSSION
CRISPR Technology: The Revived Patent Fight The Current State of Play: Patent Battles in the US in View of the USPTO Ruling What’s the Global Licensing Outlook and Where are the Opportunities?
Moderator:
Douglas Drysdale, Partner & Patent Attorney, HGF
Panellists:
Elbert Chiang, Director, Intellectual Property, Beam Therapeutics
Benjamin Sodey, Senior Corporate Patent Counsel, Millipore Sigma
Morning Coffee and Networking in the Exhibition Hall
European Focus: An Interview With Powell Gilbert
Zoe Butler, Partner, Powell Gilbert
Penny Gilbert, Partner, Powell Gilbert
PANEL DISCUSSION
Artificial Intelligence & Intellectual Property in the Life Sciences
- How is AI Disrupting the Patent Strategies of Life Sciences Companies?
- What are the Likely Implications of AI on Patenting and Licensing Strategies?
- Should you Develop a Trade Secrets Strategy?
Moderator:
Brian Slater, Partner & co-chair of life sciences, Pierce Bainbridge Beck Price & Hecht
Panellists:
John Sninsky, Independent Consultant in Translational Sciences
North of the Border: Overview of Biologics and Biosimilars in Canada
-
Overview of Canada’s Regulatory and Intellectual Property Regimes as they apply to Biologics and Biosimilars
-
The Regulatory Pathway for Marketing Approval, Data Protection, Patent Linkage and Litigation, and Current Biosimilar Approvals and Applications
-
A Comparison to the US and European Regimes: Differences and Similarities with Canada
Urszula Wojtyra, IP Lawyer and Partner, Smart & Biggar
David Schwartz, Partner, Smart & Biggar
Lunch and Networking in the Exhibition Hall
PANEL DISCUSSION
Fully Exploiting your Innovations: Best Practice in Invention Harvesting
- Identifying what to Patent Approaches to Invention Harvesting
- Brainstorming Steps and Conducting a Review of Developed and Developing Technologies Within your Organization
Moderator:
John Rearick, Principal, Choate Hall & Stewart
Panellists:
Cara Lowen, Vice President and Chief Patent Counsel, Codiak BioSciences
Anita Terpstra, Vice President, IP Counsel, Puretech Health
Natasha Jones, Commercialization Manager, University of Kentucky
Catherine Eckenswiller, Legal Counsel, VBI Vaccines
IN HOUSE ATTORNEY PANEL DISCUSSION
- What are our Most Significant Current Challenges?
- What do we want from External Attorneys?
- How can the Two Sides Best Work Together?
Moderator:
Chad Davis, Partner, Dechert
Panellists:
Shahan Islam, Senior Corporate Counsel, Pfizer
Cara Lowen, Vice President and Chief Patent Counsel, Codiak BioSciences
Kevin McGough, Vice President-Intellectual Property, Takeda Pharmaceutical Company
Anita Terpstra, Vice President, IP Counsel, Puretech Health
Catherine Eckenswiller, Legal Counsel, VBI Vaccines
Afternoon Tea and Networking in the Exhibition Hall
How is AI Disrupting the Patent Strategies of Life Sciences Companies - What are the Likely Implications of AI on Patenting and Licensing Strategies?
Anna Yuan, Associate, Morrison & Foerster
Matt Karlyn, Partner, Morrison & Foerster
BIOLOGICS PANEL DISCUSSION
Championing Cutting Edge Innovation with Robust Patent Protection: Who’s setting the agenda on biologics?
Moderator:
Nicole Clouse, Partner, McDermott Will & Emery
Panellists:
Ahmed Mousa, Vice President, General Counsel & Corporate Secretary, Pieris Pharmaceuticals
Karam Hijji, Senior IP Counsel, Pieris Pharmaceuticals
Michael Yamauchi, Sr. Director and Patent Counsel, Alexion Pharmaceuticals
Ensuring Effective Protection for Your Antibodies Portfolio
- The Impact of Amgen v Sanofi
- How Can we Ensure that the Elevated USPTO Written Description Standard is Met?
Moderator:
TBC
Panellists:
Michael Yamauchi , Sr. Director and Patent Counsel, Alexion Pharmaceuticals
Ahmed Mousa, Vice President, General Counsel & Corporate Secretary, Pieris Pharmaceuticals
Karam Hijji, Senior IP Counsel, Pieris Pharmaceuticals
Atsuko Polzin, Vice President, Intellectual Property, Scholar Rock
Chairman’s Day One Closing Remarks
Gala Dinner Welcome Drinks Reception
Life Sciences Patent Network Gala Dinner
Day 02
Thursday, May 14, 2020
US Patent Legal Landscape Outlook: What are the Main Challenges Facing the US Patent System and how do we Prepare for them?
- US Supreme Court Update
- Is the Existing IP System fit for Purpose?
David Korn, Vice President, Intellectual Property and Law, The Pharmaceutical Research and Manufacturers of America (PhRMA)
ROUNDTABLE DISCUSSION GROUPS – ROTATIONS 1 & 2
Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunities to share knowledge and opinion.
Patenting Artificial Intelligence
Best Practice in IP Portfolio Strategy
Sharon Sintich, Partner, Marshall Gerstein
Shelley Danek, Partner, Marshall Gerstein
FDA Focus: Regulatory Law in the Life Sciences
Licensing Strategies
Patenting Precision Medicine
Patenting Biologics and Biosimilars
Patenting Antibodies in the Current Climate
Filko Prugo, Partner, Ropes & Gray
Charlotte Jacobsen, Partner, Ropes & Gray
Navigating the New CRISPR Patent and Licensing Landscape
Claire Irvine, Partner & Patent Attorney, HGF
Life Sciences Patents Open Table: Solving In-House Counsel Challenges
Mark Hyman, Section Head, Pharmaceutical IP Prosecution, AbbVie
Effective Use of Supplementary Protection Certificates
Camilla Balleny, Partner, Carpmaels & Ransford
Steve Duffield, Partner, Carpmaels & Ransford
Effective Use of Patent Term Extensions
Carl Morales, Partner, Dechert
Connected Devices: Patenting Innovations Related to IoT and Blockchain
Practical Tips for Effective Invention Harvesting
Chad Davis, Partner, Dechert
Morning Coffee & Networking
Innovative IP Strategies for the Life Sciences: Best Practice in Managing Pharma and Biotech IP in the Age of Precision Medicine
Ha Kung Wong, Partner, Venable Fitzpatrick
A US Pharma Perspective on Global Patent Eligibility: The Vision and the Challenge
Mayo v Athena: A Talking Heads Interview
Effective Use of Supplementary Protection Certificates and Patent Term Extensions
The Doctrine of Equivalence: Comparing and Contrasting the Issue of Patent Infringement in the US and Europe
Paul Inman, Partner, Gowling WLG
PANEL DISCUSSION
Addressing Second Medical Use Infringement: An Evaluation of Recent SMU Cases
- What Must Generic Manufacturers do Prior to Product Launch, where a Second Medical Use Patent is in Force?
- What Practical Steps Must a Second Medical Use Patent Owner Take when Infringement is Suspected?
Lunch & Networking
ROUNDTABLE DISCUSSION GROUPS – ROTATIONS 3 & 4
Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunity to share knowledge and opinion.
Patenting Antibodies in the Current Climate
Filko Prugo, Partner, Ropes & Gray
Charlotte Jacobsen, Partner, Ropes & Gray
Navigating the New CRISPR Patent and Licensing Landscape
Claire Irvine, Partner & Patent Attorney, HGF
Licensing Strategies
Best Practice in IP Portfolio Management
Connected Devices: Patenting Innovations Related to IoT and Blockchain
FDA Focus: Regulatory Law in the Life Sciences
Life Sciences Patents Open Table: Solving In-House Counsel Challenges
Mark Hyman, Section Head, Pharmaceutical IP Prosecution, Abbvie
Patenting Biologics and Biosimilars
Patenting Precision Medicine
Practical Tips for Effective Invention Harvesting
Chad Davis, Partner, Dechert
Strategies in Second Medical Use Cases
Effective Use of Patent Term Extensions
Carl Morales, Partner, Dechert
Effective Use of Supplementary Protection Certificates
Camilla Balleny, Partner, Carpmaels & Ransford
Steve Duffield, Partner, Carpmaels & Ransford
Patenting Artificial Intelligence
Closing Keynote
Chairman’s Closing Remarks and Close of Conference
